A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease

BACKGROUND: Adenosine receptor stress agents for myocardial perfusion imaging (MPI) may cause A(2B) and/or A(3) receptor-mediated bronchoconstriction, of particular concern to physicians testing patients with asthma or chronic obstructive pulmonary disease (COPD). METHODS: A Phase 4, randomized, dou...

Descripción completa

Detalles Bibliográficos
Autores principales: Prenner, Bruce M., Bukofzer, Stan, Behm, Sarah, Feaheny, Kathleen, McNutt, Bruce E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395344/
https://www.ncbi.nlm.nih.gov/pubmed/22484721
http://dx.doi.org/10.1007/s12350-012-9547-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395344/
https://www.ncbi.nlm.nih.gov/pubmed/22484721
http://dx.doi.org/10.1007/s12350-012-9547-4

Ejemplares similares